{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:31:53Z","timestamp":1791955913377,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.4158\/ep.13.7.785","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:52:24Z","timestamp":1365198744000},"page":"785-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Suppressibility of Parathyroid Hormone in Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"13","author":[{"given":"Teck-Kim","family":"Khoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire H.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham S.","family":"Abu-Lebdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wermers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.4158\/EP.13.7.785_bb0005","first-page":"N57","article-title":"Asymptomatic primary hyperparathyroidism: new issues and new questions\u2014bridging the past with the future","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.13.7.785_bb0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0025-6196(12)60717-4","article-title":"Clinical performance of parathyroid hormone immuno-metric assays","volume":"67","author":"Kao","year":"1992","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.13.7.785_bb0015","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2002-021266","article-title":"Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyper-parathyroidism","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0020","first-page":"173","article-title":"High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria","volume":"28","author":"Glendenning","year":"1998","journal-title":"Aust N Z J Med."},{"key":"10.4158\/EP.13.7.785_bb0025","series-title":"The Parathyroids: Basic and Clinical Concepts","first-page":"356","author":"Silverberg","year":"2001"},{"key":"10.4158\/EP.13.7.785_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery."},{"key":"10.4158\/EP.13.7.785_bb0035","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1210\/jc.2006-0273","article-title":"Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves","volume":"91","author":"Lafferty","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5694\/j.1326-5377.1996.tb124924.x","volume":"165","author":"Hollenberg","year":"1996","journal-title":"Med J Aust."},{"key":"10.4158\/EP.13.7.785_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/qjmed\/93.6.365","article-title":"Primary hyperparathyroidism with normal serum intact parathyroid hormone levels","volume":"93","author":"Mischis-Troussard","year":"2000","journal-title":"QJM."},{"key":"10.4158\/EP.13.7.785_bb0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9343(86)90827-2","article-title":"Concomitant Graves\u2019 disease and primary hyperparathyroidism: influence of hyperthyroidism on serum calcium and parathyroid hormone","volume":"80","author":"Arem","year":"1986","journal-title":"Am J Med."},{"key":"10.4158\/EP.13.7.785_bb0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1993.tb00526.x","article-title":"Coincidental occurrence of primary hyperparathyroidism and cancer-associated hypercalcaemia in a middle-aged man","volume":"38","author":"Gallacher","year":"1993","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.13.7.785_bb0060","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1210\/jc.2005-1380","article-title":"1,25-Dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis","volume":"90","author":"Kinoshita","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0065","first-page":"715","article-title":"Calcium infusion suggests a \u201cset-point\u201d abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism","volume":"76","author":"Khosla","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0070","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4065\/80.8.1101","article-title":"Postural and venous stasis-induced changes in total calcium","volume":"80","author":"Heath","year":"2005","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.13.7.785_bb0075","first-page":"399","article-title":"Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis","volume":"77","author":"Samuels","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0080","first-page":"3304","article-title":"Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption","volume":"80","author":"Ledger","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/jcem-72-1-69","article-title":"Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis","volume":"72","author":"Calvo","year":"1991","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0090","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/jcem-70-4-951","article-title":"Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism","volume":"70","author":"Tohme","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.7.785_bb0100","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJM198510313131805","article-title":"Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathy-roidism","volume":"313","author":"Insogna","year":"1985","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.13.7.785_bb0105","series-title":"Principles of Competitive Protein-Binding Assays","first-page":"374","article-title":"Problems of validation of radioim-munoassays","author":"Yalow","year":"1971"},{"key":"10.4158\/EP.13.7.785_bb0110","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1373\/clinchem.2003.021592","article-title":"Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism","volume":"49","author":"D\u2019Amour","year":"2003","journal-title":"Clin Chem."},{"issue":"Pt 5","key":"10.4158\/EP.13.7.785_bb0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/000456329403100513","article-title":"Stability of parathyroid hormone-related protein and parathyroid hormone at room temperature","volume":"31","author":"Levin","year":"1994","journal-title":"Ann Clin Biochem."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20452772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20452772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/17553534772K1302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:17Z","timestamp":1761515237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20452772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1530891X20452772"],"URL":"https:\/\/doi.org\/10.4158\/ep.13.7.785","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressibility of Parathyroid Hormone in Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.13.7.785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}